Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 Apr 15;134(8):897–901.

Prevalence of hepatitis B virus infection in pregnant women in the Montreal area.

G Delage, S Montplaisir, S Rémy-Prince, E Pierri
PMCID: PMC1490941  PMID: 3955483

Abstract

From January 1982 to June 1984, 30,315 serum specimens from pregnant women at nine hospitals in the Montreal area were screened for hepatitis B surface antigen (HBsAg). Of the specimens 103, from 98 women, were positive, a prevalence rate of 3.4 per 1000. The ethnic origin of the 98 women and the number who were also positive for e antigen (HBeAg) were as follows: French-Canadian, 29 (3 HBeAg-positive); Asian, 28 (14); Haitian, 32 (0); other, 7 (0); and unknown, 2 (0). The prevalence rates of HBsAg positivity according to ethnic origin at one of the hospitals were 73.9 in Asians, 33.1 in Haitians, 0.9 in French Canadians and 8.0 in women of other extraction. If the prevalence rate found in this study is true for the 95 000 live births that occur yearly in the province of Quebec, there are an estimated 323 infants at risk for hepatitis B virus (HBV) infection each year in the province. Screening programs for detecting HBV carriage in pregnant women should be instituted, since recent studies have shown combined active-passive immunization to be effective in preventing perinatal transmission of HBV infection.

Full text

PDF
899

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldershvile J., Skinhøj P., Frösner G. G., Black F., Deinhardt F., Hardt F., Nielsen J. O. The expression pattern of hepatitis B e antigen and antibody in different ethnic and clinical groups of hepatitis B surface antigen carriers. J Infect Dis. 1980 Jul;142(1):18–22. doi: 10.1093/infdis/142.1.18. [DOI] [PubMed] [Google Scholar]
  2. Anderson K. E., Stevens C. E., Tsuei J. J., Lee W. C., Sun S. C., Beasley P. Hepatitis B antigen in infants born to mothers with chronic hepatitis B antigenemia in Taiwan. Am J Dis Child. 1975 Dec;129(12):1389–1392. doi: 10.1001/archpedi.1975.02120490007003. [DOI] [PubMed] [Google Scholar]
  3. Aziz M. A., Khan G., Khanum T., Siddiqui A. R. Transplacental and postnatal transmission of the hepatitis-associated antigen. J Infect Dis. 1973 Jan;127(1):110–112. doi: 10.1093/infdis/127.1.110. [DOI] [PubMed] [Google Scholar]
  4. Beasley R. P., Hwang L. Y., Lee G. C., Lan C. C., Roan C. H., Huang F. Y., Chen C. L. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983 Nov 12;2(8359):1099–1102. doi: 10.1016/s0140-6736(83)90624-4. [DOI] [PubMed] [Google Scholar]
  5. Beasley R. P., Hwang L. Y., Lin C. C., Stevens C. E., Wang K. Y., Sun T. S., Hsieh F. J., Szmuness W. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet. 1981 Aug 22;2(8243):388–393. doi: 10.1016/s0140-6736(81)90832-1. [DOI] [PubMed] [Google Scholar]
  6. Beasley R. P., Hwang L. Y., Stevens C. E., Lin C. C., Hsieh F. J., Wang K. Y., Sun T. S., Szmuness W. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology. 1983 Mar-Apr;3(2):135–141. doi: 10.1002/hep.1840030201. [DOI] [PubMed] [Google Scholar]
  7. Beasley R. P., Trepo C., Stevens C. E., Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977 Feb;105(2):94–98. doi: 10.1093/oxfordjournals.aje.a112370. [DOI] [PubMed] [Google Scholar]
  8. Chaudhary R. K., Nicholls E. S., Kennedy D. A. Prevalence of hepatitis B markers in Indochinese refugees. Can Med Assoc J. 1981 Dec 1;125(11):1243–1246. [PMC free article] [PubMed] [Google Scholar]
  9. Chung W. K., Yoo J. Y., Sun H. S., Lee H. Y., Lee I. J., Kim S. M., Prince A. M. Prevention of perinatal transmission of hepatitis B virus: a comparison between the efficacy of passive and passive-active immunization in Korea. J Infect Dis. 1985 Feb;151(2):280–286. doi: 10.1093/infdis/151.2.280. [DOI] [PubMed] [Google Scholar]
  10. Derso A., Boxall E. H., Tarlow M. J., Flewett T. H. Transmission of HBsAg from mother to infant in four ethnic groups. Br Med J. 1978 Apr 15;1(6118):949–952. doi: 10.1136/bmj.1.6118.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gilbert G. L. Prevention of vertical transmission of hepatitis B. The place of routine screening in antenatal care, and the case for immunization of infants at risk. Med J Aust. 1984 Aug 18;141(4):213–216. [PubMed] [Google Scholar]
  12. Goudeau A., Lo K. J., Coursaget P., Tong M. J., Yeh C. L., Tsai Y. T., Lee J. K., Wu T. C., Yeh S. H., Lee S. D. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization. Dev Biol Stand. 1983;54:399–404. [PubMed] [Google Scholar]
  13. Guévin R. M., Brown G., Taliano V. Données statistiques concernant l'antigène australia pour la région ouest du québec. Union Med Can. 1973 Jun;102(6):1260–1263. [PubMed] [Google Scholar]
  14. Lee A. K., Ip H. M., Wong V. C. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis. 1978 Nov;138(5):668–671. doi: 10.1093/infdis/138.5.668. [DOI] [PubMed] [Google Scholar]
  15. Maupas P., Chiron J. P., Barin F., Coursaget P., Goudeau A., Perrin J., Denis F., Mar I. D. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet. 1981 Feb 7;1(8215):289–292. doi: 10.1016/s0140-6736(81)91908-5. [DOI] [PubMed] [Google Scholar]
  16. Maupas P., Chiron J. P., Goudeau A., Coursaget P., Perrin J., Barin F., Denis F., Diop Mar I. Active immunization against hepatitis B in an area of high endemicity. Part II: Prevention of early infection of the child. Prog Med Virol. 1981;27:185–201. [PubMed] [Google Scholar]
  17. Miller J. A., Hermon Y. E. Hepatitis B in pregnant women. N Z Med J. 1984 Jul 11;97(759):461–461. [PubMed] [Google Scholar]
  18. Okada K., Kamiyama I., Inomata M., Imai M., Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med. 1976 Apr 1;294(14):746–749. doi: 10.1056/NEJM197604012941402. [DOI] [PubMed] [Google Scholar]
  19. Okada K., Yamada T., Miyakawa Y., Mayumi M. Hepatitis B surface antigen in the serum of infants after deliver from asymptomatic carrier mothers. J Pediatr. 1975 Sep;87(3):360–363. doi: 10.1016/s0022-3476(75)80635-4. [DOI] [PubMed] [Google Scholar]
  20. Papaevangelou G., Hoofnagle J., Kremastinou J. Transplacental transmission of hepatitis-B virus by symptom-free chronic carrier mothers. Lancet. 1974 Sep 28;2(7883):746–748. doi: 10.1016/s0140-6736(74)90942-8. [DOI] [PubMed] [Google Scholar]
  21. Reesink H. W., Reerink-Brongers E. E., Lafeber-Schut B. J., Kalshoven-Benschop J., Brummelhuis H. G. Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulin. Lancet. 1979 Sep 1;2(8140):436–438. doi: 10.1016/s0140-6736(79)91491-0. [DOI] [PubMed] [Google Scholar]
  22. Rosendahl C., Kochen M. M., Kretschmer R., Wegscheider K., Kaiser D. Avoidance of perinatal transmission of hepatitis B virus: is passive immunisation always necessary? Lancet. 1983 May 21;1(8334):1127–1129. doi: 10.1016/s0140-6736(83)92866-0. [DOI] [PubMed] [Google Scholar]
  23. Shanmugam J., Nair S. R. A three and half year follow-up study of HBs-Ag carrier state in asymptomatic mothers. Indian J Pathol Microbiol. 1982 Oct;25(4):273–278. [PubMed] [Google Scholar]
  24. Shiraki K., Yoshihara N., Sakurai M., Eto T., Kawana T. Acute hepatitis B in infants born to carrier mother with the antibody to hepatitis B e antigen. J Pediatr. 1980 Nov;97(5):768–770. doi: 10.1016/s0022-3476(80)80261-7. [DOI] [PubMed] [Google Scholar]
  25. Skinhoj P., Olesen H., Cohn J., Mikkelsen M. Hepatitis-associated antigen in pregnant women. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(3):362–366. doi: 10.1111/j.1699-0463.1972.tb00047.x. [DOI] [PubMed] [Google Scholar]
  26. Stevens C. E., Neurath R. A., Beasley R. P., Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol. 1979;3(3):237–241. doi: 10.1002/jmv.1890030310. [DOI] [PubMed] [Google Scholar]
  27. Tada H., Yanagida M., Mishina J., Fujii T., Baba K., Ishikawa S., Aihara S., Tsuda F., Miyakawa Y., Mayumi M. Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state. Pediatrics. 1982 Oct;70(4):613–619. [PubMed] [Google Scholar]
  28. Wong V. C., Ip H. M., Reesink H. W., Lelie P. N., Reerink-Brongers E. E., Yeung C. Y., Ma H. K. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984 Apr 28;1(8383):921–926. doi: 10.1016/s0140-6736(84)92388-2. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES